News blog
Flu focus pays off for GSK
GlaxoSmithKline has announced a rosy set of third-quarter financial figures, and is going to be boosted by the ongoing H1N1 outbreak.
The company says it expects further growth in the fourth quarter “including significant sales of influenza products”.
Recent comments on this blog
Experiments reveal that crabs and lobsters feel pain
US research ethics agency upholds decision on informed consent
Chemistry credit disputes under the spotlight
Chemistry credit disputes under the spotlight
Contamination created controversial ‘acid-induced’ stem cells